• 1147 Citations
  • 19 Scopus h-Index
20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2006

Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer

Ailawadhi, S., Sunga, A., Rajput, A., Yang, G. Y., Smith, J. & Fakih, M., Mar 1 2006, In : Oncology. 70, 1, p. 49-53 5 p.

Research output: Contribution to journalArticle

26 Scopus citations
2007

Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma

Ailawadhi, S., Nagase, H., Khoury, T., Yu, J., Tan, D., Black, J., Brattain, M. & Javle, M., Jul 1 2007, In : Hepato-Gastroenterology. 54, 77, p. 1339-1344 6 p.

Research output: Contribution to journalArticle

3 Scopus citations

Serotonin syndrome caused by interaction between citalopram and fentanyl

Ailawadhi, S., Sung, K. W., Carlson, L. A. & Baer, M. R., Apr 1 2007, In : Journal of Clinical Pharmacy and Therapeutics. 32, 2, p. 199-202 4 p.

Research output: Contribution to journalArticle

48 Scopus citations
2009

Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: Results of a phase II clinical trial

Chanan-Khan, A., Miller, K. C., Musial, L., Padmanabhan, S., Yu, J., Ailawadhi, S., Sher, T., Mohr, A., Bernstein, Z. P., Barcos, M., Patel, M., Iancu, D., Lee, K. & Czuczman, M. S., Aug 17 2009, In : Leukemia and Lymphoma. 50, 7, p. 1096-1101 6 p.

Research output: Contribution to journalArticle

26 Scopus citations

Erlotinib for metastatic non-small-cell lung cancer: First-, second- or third-line setting - Does it matter? A single-institution experience

Ailawadhi, S., Derby, L., Natarajan, R., Fetterly, G., Reid, M. & Ramnath, N., Feb 1 2009, In : Oncology. 76, 2, p. 85-90 6 p.

Research output: Contribution to journalArticle

9 Scopus citations
2010

Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma

Ailawadhi, S., Abdelhalim, A. N., Derby, L., Mashtare, T. L., Miller, K. C., Wilding, G. E., Alberico, R. A., Gottlieb, R., Klippenstein, D. L., Lee, K. & Chanan-Khan, A. A., Jan 1 2010, In : Cancer. 116, 1, p. 84-92 9 p.

Research output: Contribution to journalArticle

15 Scopus citations
2011

A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients

Sher, T., Ailawadhi, S., Miller, K. C., Manfredi, D., Wood, M., Tan, W., Wilding, G., Czuczman, M. S., Hernandez-Ilizaliturri, F. J., Hong, F., Sood, R., Soniwala, S., Lawrence, W., Jamshed, S., Masood, A., Iancu, D., Lee, K. & Chanan-Khan, A., Jul 2011, In : British journal of haematology. 154, 1, p. 104-110 7 p.

Research output: Contribution to journalArticle

11 Scopus citations
2012

Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma

Ailawadhi, S., Miecznikowski, J., Gaile, D. P., Wang, D., Sher, T., Mulligan, G., Bryant, B., Wilding, G. E., Mashtare, T., Stein, L., Masood, A., Neuwirth, R., Lee, K. P. & Chanan-Khan, A., Jun 1 2012, In : Leukemia and Lymphoma. 53, 6, p. 1174-1182 9 p.

Research output: Contribution to journalArticle

14 Scopus citations

Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner

Masood, A., Chitta, K., Paulus, A., Khan, A. N. H., Sher, T., Ersing, N., Miller, K. C., Manfredi, D., Ailawadhi, S., Borrelo, I., Lee, K. P. & Chanan-Khan, A. A., Apr 1 2012, In : British journal of haematology. 157, 1, p. 59-66 8 p.

Research output: Contribution to journalArticle

19 Scopus citations

Outcome disparities in multiple myeloma: A SEER-based comparative analysis of ethnic subgroups

Ailawadhi, S., Aldoss, I. T., Yang, D., Razavi, P., Cozen, W., Sher, T. & Chanan-Khan, A., Jul 1 2012, In : British journal of haematology. 158, 1, p. 91-98 8 p.

Research output: Contribution to journalArticle

42 Scopus citations
2013

Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute- Waldenström Macroglobulinemia 1

Chitta, K. S., Paulus, A., Ailawadhi, S., Foster, B. A., Moser, M. T., Starostik, P., Masood, A., Sher, T., Miller, K. C., Iancu, D. M., Conroy, J., Nowak, N. J., Sait, S. N., Personett, D. A., Coleman, M., Furman, R. R., Martin, P., Ansell, S. M., Lee, K. & Chanan-Khan, A. A., Feb 1 2013, In : Leukemia and Lymphoma. 54, 2, p. 387-396 10 p.

Research output: Contribution to journalArticle

16 Scopus citations

Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics

Razavi, P., Rand, K. A., Cozen, W., Chanan-Khan, A., Usmani, S. & Ailawadhi, S., Jun 1 2013, In : Blood cancer journal. 3, 6, e121.

Research output: Contribution to journalArticle

35 Scopus citations

Reactivation of Chagas disease in a bone marrow transplant patient: Case report and review of screening and management

Guiang, K. M. U., Cantey, P., Montgomery, S. P., Ailawadhi, S., Qvarnstrom, Y., Price, T. & Blodget, E., Dec 1 2013, In : Transplant Infectious Disease. 15, 6, p. E264-E267

Research output: Contribution to journalArticle

8 Scopus citations
2014

Deep sequencing reveals lack of a clonal relationship between a metachronous classical hodgkin and diffuse large B-cell lymphoma

Siddiqi, I. N., Ailawadhi, S., Huang, Q., Shibata, R. K., Kang, H. & Shibata, D., Jun 2014, In : Clinical Lymphoma, Myeloma and Leukemia. 14, 3, p. e87-e93

Research output: Contribution to journalArticle

2 Scopus citations

Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia

Chitta, K., Paulus, A., Caulfield, T., Akhtar, S., Blake, M. K. K., Ailawadhi, S., Knight, J., Heckman, M. G., Pinkerton, A. & Chanan Khan, A. A., Jan 1 2014, In : Blood Cancer Journal. 4, 11, e260.

Research output: Contribution to journalArticle

13 Scopus citations

Outcome disparities among ethnic subgroups of waldenström's macroglobulinemia: A population-based study

Ailawadhi, S., Kardosh, A., Yang, D., Cozen, W., Patel, G., Alamgir, M. A. & Chanan-Khan, A. A., Jul 2014, In : Oncology (Switzerland). 86, 5-6, p. 253-262 10 p.

Research output: Contribution to journalArticle

12 Scopus citations

Pharmacoeconomic implications of lenalidomide maintenance therapy in multiple myeloma

Kim, M. Y., Sposto, R., Swaika, A., Asano, H., Alamgir, A., Chanan-Khan, A. & Ailawadhi, S., Nov 7 2014, In : Oncology (Switzerland). 87, 4, p. 224-231 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups

Ailawadhi, S., Swaika, A., Razavi, P., Yang, D. & Chanan Khan, A. A., Jan 1 2014, In : Blood Cancer Journal. 4, 9, e243.

Research output: Contribution to journalArticle

9 Scopus citations
2015

Financial burden after allogeneic hematopoietic cell transplantation: A qualitative analysis from the patient's perspective

Kim, W., McNulty, J., Chang, Y. H., Weise, M., Hashmi, S., Ailawadhi, S. & Khera, N. D., Sep 4 2015, In : Bone Marrow Transplantation. 50, 9, p. 1259-1261 3 p.

Research output: Contribution to journalArticle

14 Scopus citations

Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: Potential biological and therapeutic implications

Paulus, A., Chitta, K. S., Wallace, P. K., Advani, P. P., Akhtar, S., Kuranz-Blake, M., Ailawadhi, S. & Chanan Khan, A. A., Apr 8 2015, In : PLoS One. 10, 4, e0122338.

Research output: Contribution to journalArticle

8 Scopus citations
11 Scopus citations
33 Scopus citations

Treatment of Immunoglobulin Light Chain Amyloidosis Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

Dispenzieri, A., Buadi, F., Kumar, S. K., Reeder, C. B., Sher, T., Lacy, M., Kyle, R. A., Mikhael, J. R., Roy, V., Leung, N., Grogan, M., Kapoor, P., Lust, J. A., Dingli, D. M., Go, R. S., Hwa, Y. L., Hayman, S. R., Fonseca, R., Ailawadhi, S., Bergsagel, P. L. & 6 others, Chanan Khan, A. A., Rajkumar, S. V., Russell, S. J., Stewart, A. K., Zeldenrust, S. R. & Gertz, M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1054-1081 28 p.

Research output: Contribution to journalArticle

68 Scopus citations
2016

A meta-analysis of multiple myeloma risk regions in African and European ancestry populations identifies putatively functional loci

Rand, K. A., Song, C., Dean, E., Serie, D. J., Curtin, K., Sheng, X., Hu, D., Huff, C. A., Bernal-Mizrachi, L., Tomasson, H. M., Ailawadhi, S., Singhal, S., Pawlish, K., Peters, E. S., Bock, C. H., Stram, A., Van Den Berg, D. J., Edlund, C. K., Conti, D. V., Zimmerman, T. & 82 others, Hwang, A. E., Huntsman, S., Graff, J., Nooka, A., Kong, Y., Pregja, S. L., Berndt, S. I., Blot, W. J., Carpten, J., Casey, G., Chu, L., Diver, W. R., Stevens, V. L., Lieber, M. R., Goodman, P. J., Hennis, A. J. M., Hsing, A. W., Mehta, J., Kittles, R. A., Kolb, S., Klein, E. A., Leske, C., Murphy, A. B., Nemesure, B., Neslund-Dudas, C., Strom, S. S., Vij, R., Rybicki, B. A., Stanford, J. L., Signorello, L. B., Witte, J. S., Ambrosone, C. B., Bhatti, P., John, E. M., Bernstein, L., Zheng, W., Olshan, A. F., Hu, J. J., Ziegler, R. G., Nyante, S. J., Bandera, E. V., Birmann, B. M., Ingles, S. A., Press, M. F., Atanackovic, D., Glenn, M. J., Cannon-Albright, L. A., Jones, B., Tricot, G., Martin, T. G., Kumar, S. K., Wolf, J. L., Deming Halverson, S. L., Rothman, N., Brooks-Wilson, A. R., Rajkumar, S. V., Kolonel, L. N., Chanock, S. J., Slager, S. L., Severson, R. K., Janakiraman, N., Terebelo, H. R., Brown, E. E., De Roos, A. J., Mohrbacher, A. F., Colditz, G. A., Giles, G. G., Spinelli, J. J., Chiu, B. C., Munshi, N. C., Anderson, K. C., Levy, J., Zonder, J. A., Orlowski, R. Z., Lonial, S., Camp, N. J., Vachon, C. M., Ziv, E., Stram, D. O., Hazelett, D. J., Haiman, C. A. & Cozen, W., Dec 1 2016, In : Cancer Epidemiology Biomarkers and Prevention. 25, 12, p. 1609-1618 10 p.

Research output: Contribution to journalArticle

7 Scopus citations

Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells

Paulus, A., Akhtar, S., Caulfield, T., Samuel, K., Yousaf, H., Bashir, Y., Paulus, S. M., Tran, D., Hudec, R., Cogen, D., Jiang, J., Edenfield, B., Novak, A. J., Ansell, S. M., Witzig, T. E., Martin, P., Coleman, M., Roy, V., Ailawadhi, S., Chitta, K. & 2 others, Linder, S. & Chanan Khan, A. A., Nov 4 2016, In : Blood Cancer Journal. 6, 11, e492.

Research output: Contribution to journalArticle

20 Scopus citations

IAP antagonists induce anti-tumor immunity in multiple myeloma

Chesi, M., Mirza, N. N., Garbitt, V. M., Sharik, M. E., Dueck, A., Asmann, Y., Akhmetzyanova, I., Kosiorek, H. E., Calcinotto, A., Riggs, D. L., Keane, N., Ahmann, G. J., Morrison, K. M., Fonseca, R., Lacy, M., Dingli, D. M., Kumar, S. K., Ailawadhi, S., Dispenzieri, A., Buadi, F. & 7 others, Gertz, M., Reeder, C. B., Lin, Y., Chanan Khan, A. A., Stewart, A. K., Fooksman, D. & Bergsagel, P. L., Dec 1 2016, In : Nature Medicine. 22, 12, p. 1411-1420 10 p.

Research output: Contribution to journalArticle

59 Scopus citations

Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis

Ailawadhi, S., Advani, P., Yang, D., Ghosh, R., Swaika, A., Roy, V., Foran, J. M., Colon-Otero, G. & Chanan Khan, A. A., Feb 15 2016, In : Cancer. 122, 4, p. 618-625 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., LaPlant, B. R., Reeder, C. B., Roy, V., Halvorson, A. E., Buadi, F., Gertz, M., Bergsagel, P. L., Dispenzieri, A., Thompson, M. A., Crawley, J., Kapoor, P., Mikhael, J. R., Stewart, A. K., Hayman, S. R., Hwa, Y. L., Gonsalves, W., Witzig, T. E., Ailawadhi, S., Dingli, D. M. & 5 others, Go, R. S., Lin, Y., Rivera, C. E., Rajkumar, S. V. & Lacy, M., Nov 17 2016, In : Blood. 128, 20, p. 2415-2422 8 p.

Research output: Contribution to journalArticle

30 Scopus citations

Re: FDG PET/CT Findings of Intracardiac Myeloid Sarcoma

Sahu, K. K., Gautam, A. & Ailawadhi, S., Nov 4 2016, (Accepted/In press) In : Clinical Nuclear Medicine.

Research output: Contribution to journalArticle

9 Scopus citations
2017

Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion

Waddle, M., Irvin, M., Gupta, E., Gibbs, M., Kakar, T. S., Gannon, N. A., Arthurs, J. R., Fischer, D. L. & Ailawadhi, S., May 16 2017, (Accepted/In press) In : Chemotherapy. p. 295-300 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Correlation of sociodemographic and clinical parameters with depression and distress in patients with hematologic malignancies

Shreders, A. J., Niazi, S. K., Hodge, D. O., Chimato, N. T., Kureti, M., Kirla, N., Agrawal, A., Swaika, A., Gustetic, E., Foster, R., Nelson, K. A., Jani, P., Chanan Khan, A. A. & Ailawadhi, S., Dec 7 2017, (Accepted/In press) In : Annals of Hematology. p. 1-10 10 p.

Research output: Contribution to journalArticle

3 Scopus citations

Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States

Jakubowiak, A. J., Houisse, I., Májer, I., Benedict, Á., Campioni, M., Panjabi, S. & Ailawadhi, S., Dec 2 2017, In : Expert Review of Hematology. 10, 12, p. 1107-1119 13 p.

Research output: Contribution to journalArticle

11 Scopus citations

Cost-effectiveness of Pomalidomide, Carfilzomib, and Daratumumab for the Treatment of Patients with Heavily Pretreated Relapsed-refractory Multiple Myeloma in the United States

Pelligra, C. G., Parikh, K., Guo, S., Chandler, C., Mouro, J., Abouzaid, S. & Ailawadhi, S., 2017, (Accepted/In press) In : Clinical Therapeutics.

Research output: Contribution to journalArticle

11 Scopus citations

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

Paludo, J., Abeykoon, J. P., Kumar, S., Shreders, A., Ailawadhi, S., Gertz, M. A., Kourelis, T., King, R. L., Reeder, C. B., Leung, N., Kyle, R. A., Buadi, F. K., Habermann, T. M., Dingli, D., Witzig, T. E., Dispenzieri, A., Lacy, M. Q., Go, R. S., Lin, Y., Gonsalves, W. I. & 5 others, Warsame, R., Lust, J. A., Rajkumar, S. V., Ansell, S. M. & Kapoor, P., Oct 2017, In : British journal of haematology. 179, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

7 Scopus citations
50 Scopus citations

Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?

Ailawadhi, S., Bhatia, K., Aulakh, S., Meghji, Z. & Chanan Khan, A. A., Jun 19 2017, (Accepted/In press) In : Current Hematologic Malignancy Reports. p. 1-8 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

Extramedullary solitary plasmacytoma: Demonstrating the role of 18F-FDG PET imaging

Gautam, A., Sahu, K. K., Alamgir, A., Siddiqi, I. & Ailawadhi, S., Apr 1 2017, In : Journal of Clinical and Diagnostic Research. 11, 4, p. XD01-XD03

Research output: Contribution to journalArticle

8 Scopus citations

Molecular modeling and functional analysis of exome sequencing-derived variants of unknown significance identify a novel, constitutively active FGFR2 mutant in cholangiocarcinoma

Egan, J. B., Marks, D. L., Hogenson, T. L., Vrabel, A. M., Sigafoos, A. N., Tolosa, E. J., Carr, R. M., Safgren, S. L., Hesles, E. E., Almada, L. L., Romecin-Duran, P. A., Iguchi, E., Ala'Aldeen, A., Kocher, J. P. A., Oliver, G. R., Prodduturi, N., Mead, D. W., Hossain, A., Huneke, N. E., Tagtow, C. M. & 43 others, Ailawadhi, S., Ansell, S. M., Banck, M. S., Bryce, A. H., Carballido, E. M., Chanan-Khan, A. A., Curtis, K. K., Resnik, E., Gawryletz, C. D., Go, R. S., Halfdanarson, T. R., Ho, T. H., Joseph, R. W., Kapoor, P., Mansfield, A. S., Meurice, N., Rao, A. A. N., Nowakowski, G. S., Pardanani, A., Parikh, S. A., Cheville, J. C., Feldman, A. L., Ramanathan, R. K., Robinson, S. I., Tibes, R., Finnes, H. D., McCormick, J. B., McWilliams, R. R., Jatoi, A., Patnaik, M. M., Silva, A. C., Wieben, E. D., McAllister, T. M., Rumilla, K. M., Kerr, S. E., Lazaridis, K. N., Farrugia, G., Keith Stewart, A., Clark, K. J., Kennedy, E. J., Klee, E. W., Borad, M. J. & Fernandez-Zapico, M. E., Jan 1 2017, In : JCO Precision Oncology. 2017, 1, p. 1-13 13 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

Paludo, J., Mikhael, J. R., Laplant, B. R., Halvorson, A. E., Kumar, S., Gertz, M. A., Hayman, S. R., Buadi, F. K., Dispenzieri, A., Lust, J. A., Kapoor, P., Leung, N., Russell, S. J., Dingli, D., Go, R. S., Lin, Y., Gonsalves, W. I., Fonseca, R., Bergsagel, P. L., Roy, V. & 8 others, Sher, T., Chanan-Khan, A. A., Ailawadhi, S., Stewart, A. K., Reeder, C. B., Richardson, P. G., Rajkumar, S. V. & Lacy, M. Q., Sep 7 2017, In : Blood. 130, 10, p. 1198-1204 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

Prevalence of BCL-2/J(H) Translocation in Healthy African Americans

Colon-Otero, G., Van Wier, S. A., Ahmann, G. J., Braggio, E. D., Albertie, M. L., Weis, J. A., Ailawadhi, S., Cerhan, J. R., Vishnu, P., Jorgensen, M. S., Foran, J. M., Thomas, C. S. & Fonseca, R., Jan 1 2017, In : Annals of Hematology. 96, 1, p. 51-55 5 p.

Research output: Contribution to journalArticle

Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant

Dholaria, B., Patel, R. J., Sluzevich, J. C., Ailawadhi, S. & Roy, V., Sep 6 2017, (Accepted/In press) In : Annals of Hematology. p. 1-2 2 p.

Research output: Contribution to journalArticle

3 Scopus citations

Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment

Vidisheva, A. P., Wang, J., Spektor, T. M., Bitran, J. D., Lutzky, J., Tabbara, I. A., Ye, J. Z., Ailawadhi, S., Stampleman, L. V., Steis, R. G., Moezi, M. M., Swift, R. A., Maluso, T. M., Udd, K. A., Eshaghian, S., Nassir, Y. & Berenson, J. R., Apr 28 2017, (Accepted/In press) In : Supportive Care in Cancer. p. 1-8 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Second primary acute lymphoblastic leukemia in adults: A SEER analysis of incidence and outcomes

Swaika, A., Frank, R. D., Yang, D., Finn, L. E., Jiang, L., Advani, P., Chanan-Khan, A. A., Ailawadhi, S. & Foran, J. M., Jan 1 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

14 Scopus citations
15 Scopus citations
2018

AlternativeOutpatientChemotherapy scheduling method to improve patient service quality and nurse satisfaction

Huang, Y. L., Bryce, A. H., Culbertson, T., Connor, S. L., Looker, S. A., Altman, K. M., Collins, J. G., Stellner, W., Mc Williams, R. R., Moreno Aspitia, A., Ailawadhi, S. & Mesa, R. A., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. e82-e91

Research output: Contribution to journalArticle

1 Scopus citations

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 others, Hayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

15 Scopus citations

Disease and outcome disparities in multiple myeloma: Exploring the role of race/ethnicity in the Cooperative Group clinical trials

Ailawadhi, S., Jacobus, S., Sexton, R., Stewart, A. K., Dispenzieri, A., Hussein, M. A., Zonder, J. A., Crowley, J., Hoering, A., Barlogie, B., Orlowski, R. Z. & Rajkumar, S. V., Jul 1 2018, In : Blood Cancer Journal. 8, 7, 67.

Research output: Contribution to journalArticle

12 Scopus citations

Impact of initial treatment (tx) on HRQoL and outcomes in patients (pts) with newly diagnosed multiple myeloma (NDMM) without intent for immediate transplant (SCT): Results from the Connect® MM registry

Abonour, R., Rifkin, R. M., Gasparetto, C., Toomey, K., Durie, B. G. M., Hardin, J. W., Terebelo, H. R., Jagannath, S., Narang, M., Ailawadhi, S., Srinivasan, S., Kitali, A., Agarwal, A. & Wagner, L., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii360

Research output: Contribution to journalArticle

Open Access

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma

Niazi, S. K., Frank, R. D., Sharma, M., Roy, V., Ames, S. C., Rummans, T. A., Spaulding, A., Sher, T., Ailawadhi, M., Bhatia, K., Ahmed, S., Tan, W., Chanan-Khan, A. & Ailawadhi, S., May 22 2018, In : Blood Advances. 2, 10, p. 1120-1128 9 p.

Research output: Contribution to journalArticle

1 Scopus citations